MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer

Background: Immune checkpoint inhibitors have changed the treatment landscape for advanced non-small cell lung cancer. However, only a small proportion of patients experience clinical benefit from ICIs. Thus, the discovery of predictive biomarkers is urgently warranted. Evidence have shown that gene...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Lei Sun, Man Li, Ling Deng, Yuchun Niu, Yichun Tang, Yu Wang, Linlang Guo
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2021-04-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	MGA mutation non-squamous non-small cell lung cancer biomarker immune checkpoint inhibitors
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fphar.2021.625593/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!